The New Zealand General Practice Podcast

Dr Dave catches Dr Jo up on Measles clinical signs, testing, management, complications, and vaccination advice, NSAID use in CKD and Methotrexate without folic acid. Disability Allowance updates – special food form, CGM funding considerations. Cremation Regulations exemption extended – process and applicability. Concussion Guidelines – new ANZ guidance and assessment tools. RNZCGP position statement on 12‑month prescribing – regulatory changes and practice policy guidance. Resources
Angina Action Plan (multi‑language) 
Birth Trauma Screening Tool (City Birth Trauma Scale) 
Online learning modules for bowel screening 
Antibiotic stewardship (Te Whata Kura) 
Adult ADHD – webinar information

Dr Dave teaches Dr Jo about
Restless leg syndrome, Pregabalin prescribing, Ryeqo for endometriosis, Nortriptyline, Signs in acute coronary syndrome, SCAD a new HQSC cultural resource and other Resources for STI patient info, Herpes guidelines, Cybersecurity for primary care and the Miscarriage Matters website.

Dr Dave teaches Dr Jo about

Valproate in women of childbearing age

Triple whammy

Macrolides + statins

Carotid artery POCUS

Insomnia meds

New sepsis guidance

Pharmac SA updates

Alzheimer disease advances

Research Review gems

BNP levels on Pasifika patients

Varenicline for vaping cessation and

Vitamin K2 for nocturnal leg cramps

Dr Dave teaches Dr Jo about Suicide prevention with new NHS and NICE guidance discouraging risk stratification tools and instead emphasising relational safety, a biopsychosocial approach, dynamic safety planning, inclusivity, and clear communication. Dr Dave covers paediatric gastroenteritis, a recent NEJM study confirms oral ondansetron’s effectiveness in reducing vomiting in children, with NZFC guidance supporting its use for dehydration-related cases. Privacy and safety intersect in the discussion of HIPC Rule 11, which allows clinicians to disclose health information without consent if there is a serious threat to life or health, provided specific criteria are met and documentation is thorough. In diabetes care, once-weekly insulin icodec is found to be as effective as daily long-acting insulins, though it is not yet approved in New Zealand and is more costly. Insomnia management advances include the approval of lemborexant, a DORA, with evidence supporting its efficacy and safety, though it remains unsubsidised. COPD management is updated with guidance on triple therapy and the role of eosinophil counts, while iron deficiency is clarified with new diagnostic and monitoring recommendations. Finally, Dr Jo learns about some adult ADHD management resources and gets recent insights into QTc-prolonging medications.

Dr Dave teaches Dr Jo about Malnutrition detection and management, the Breast screening age extension, Serum estradiol measurement in menopause, Anticoagulant monitoring equity concerns, Prostate cancer screening and digital rectal exam, Optimal Cancer Care Pathways (OCCPs), FIT for Symptomatic bowel pathway, Oral iron tablet supply issue:, and Adrenaline administration by vaccinators.
Apologies for the delayed publication of this epsiode.